EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review

Fang Zhao, Hongzhou Lu

BioScience Trends · 2024

DOI: 10.5582/bst.2024.01062 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioScience Trends, 2024. Verfasst von Fang Zhao und 1 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern Uni…. Hauptthemen laut MEDLINE: Tenofovir, HIV Infections, Alanine, Adenine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 78 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antiretroviral therapy (ART) has significantly enhanced the outlook for people with HIV(PWH), yet certain ART medications can adversely affect the renal function of these patients. Of particular concern is the nephrotoxicity associated with tenofovir disoproxil fumarate (TDF). Compared to TDF, tenofovir alafenamide (TAF), another prodrug of tenofovir (TFV), results in lower TFV plasma levels, thereby alleviating the TFV-associated mitochondrial toxicity on proximal renal tubular cells. Currently, numerous clinical trials and real-world studies have demonstrated the favorable renal safety profile of ART regimens incorporating TAF for PWH. This paper seeks to consolidate the available evidence regarding the renal safety of TAF-based regimens in PWH, encompassing both the general PWH and those with renal impairment or predisposing factors, in order to offer recommendations and insights for TAF clinical application.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TenofovirHIV InfectionsAlanineAdenineAnti-HIV AgentsHumansKidney

Stichwörter der Autor:innen

people with HIV (PWH)renal safetytenofovir alafenamide (TAF)

Substanzen

Tenofovirtenofovir alafenamideAlanineAdenineAnti-HIV Agents

Autor:innen und Institutionen

  • National Clinical Research Centre for Infectious Diseases, The Third People's Hospital of Shenzhen and The Second Affiliated Hospital of Southern University of Science and Technology, Shenzhen, Guangdong, China.

Zitieren

APA

Zhao, F., & Lu, H. (2024). Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review. BioScience Trends. https://doi.org/10.5582/bst.2024.01062

Vancouver

Zhao F, Lu H. Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review. BioScience Trends. 2024. doi:10.5582/bst.2024.01062

BibTeX
@article{Zhao2024,
  author = {Zhao, Fang and Lu, Hongzhou},
  title = {Renal safety of tenofovir alafenamide-based antiretroviral therapy in people with HIV: A mini-review},
  journal = {BioScience Trends},
  year = {2024},
  doi = {10.5582/bst.2024.01062}
}
Kostenlos starten →